Correlation Between Hookipa Pharma and AVROBIO
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and AVROBIO, you can compare the effects of market volatilities on Hookipa Pharma and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and AVROBIO.
Diversification Opportunities for Hookipa Pharma and AVROBIO
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hookipa and AVROBIO is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and AVROBIO go up and down completely randomly.
Pair Corralation between Hookipa Pharma and AVROBIO
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the AVROBIO. In addition to that, Hookipa Pharma is 2.09 times more volatile than AVROBIO. It trades about -0.19 of its total potential returns per unit of risk. AVROBIO is currently generating about -0.13 per unit of volatility. If you would invest 145.00 in AVROBIO on September 3, 2024 and sell it today you would lose (5.00) from holding AVROBIO or give up 3.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 9.6% |
Values | Daily Returns |
Hookipa Pharma vs. AVROBIO
Performance |
Timeline |
Hookipa Pharma |
AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Hookipa Pharma and AVROBIO Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and AVROBIO
The main advantage of trading using opposite Hookipa Pharma and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |